Clonal evolution in a patient with aplastic anemia – case report
References
- 1. Kaito K, Kobayashi M, Katayama T, et al. Long-term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults. Br J Haematol. 1998;103:297-303.
- 2. Maciejewski JP, Risitano A, Sloand EM, Nunez O, Young NS. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood 2002;99:3129-3135.
- 3. Maciejewski JP, Selleri C. Evolution of clonal cytogenetic abnormalities in aplastic anemia. Leuk Lymphoma. 2004; 45:433-440.
- 4. Appelbaum FR, Barrall J, Storb R, et al. Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia. Exp Hematol. 1987; 15:1134-1139
- 5. Tichelli A, Gratwohl A, Wursch A, Nissen C, Speck B. Late haematological complications in severe aplastic anaemia. Br J Haematol. 1988; 69:413-418.
- 6. Sergej K, L. Jeffrey M, Patrick A, et al. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia. Cancer. 2007; 110(7):1520-1526.
- 7. John M. Bennett, Attilio o, et al. Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach. Haematologica 2009; 94(2):264-268
- 8. Seiji K, Akira O, et al. Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood. 2002; 100(3):786-790.
- 9. Phillip Scheinberg, Neal S. Young, How I treat acquired aplastic anemia. Blood. 2012 Aug 9; 120(6): 1185-1196
DOI: https://doi.org/10.1515/dch-2015-0004 | Journal eISSN: 1582-196X
Language: English
Page range: 45 - 51
Published on: Feb 12, 2016
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Related subjects:
© 2016 Melen Brinza, Cerasela Jardan, Didona Vasilache, Camelia Dobrea, Daniel Coriu, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.